Literature DB >> 7713759

Evaluation of novel formulations of 35S- and 33P-labelled nucleotides for in situ hybridization.

I Durrant1, B Dacre, M Cunningham.   

Abstract

Radioactive in situ hybridization predominantly utilizes either RNA probes or oligonucleotide probes. The properties of various formulations of [35S]UTP alpha S have been studied with respect to probe labelling and when applied to in situ hybridization. A new formulation has been prepared that combines a high physical concentration with a high specific activity so that, theoretically, predominantly full-length, high-specific-activity primary transcripts are produced. [alpha-33P]UTP can also be used for in situ hybridization and it compares favourably to 35S-labelled probes in terms of resolution and sensitivity. Both radiolabels can also be used to label oligonucleotide probes by a tailing reaction. [35S]dATP alpha S has been reformulated specifically for labelling oligonucleotides. The traditional stabilizer, dithiothreitol, which may cause precipitation within the tailing reaction buffer, has been replaced with an alternative stabilizer that avoids this problem while maintaining the stability of the nucleotide.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7713759     DOI: 10.1007/bf00164176

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  2 in total

1.  32P, 33P and 35S: selecting a label for nucleic acid analysis.

Authors:  M R Evans; C A Read
Journal:  Nature       Date:  1992-08-06       Impact factor: 49.962

2.  Detection of mrnas in sea urchin embryos by in situ hybridization using asymmetric RNA probes.

Authors:  K H Cox; D V DeLeon; L M Angerer; R C Angerer
Journal:  Dev Biol       Date:  1984-02       Impact factor: 3.582

  2 in total
  1 in total

Review 1.  In situ hybridization in the pathology laboratory: general principles, automation, and emerging research applications for tissue-based studies of gene expression.

Authors:  David G Hicks; Gabe Longoria; James Pettay; Tom Grogan; Shannon Tarr; Raymond Tubbs
Journal:  J Mol Histol       Date:  2004-08       Impact factor: 2.611

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.